Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,388 | -34,808 | -17,165 | -129,865 | -76,616 |
| Depreciation Amortization | -1,583 | -1,053 | -441 | -1,610 | -1,367 |
| Other Working Capital | -38,032 | -38,177 | -40,040 | 25,907 | -11,975 |
| Other Operating Activity | 15,860 | 10,353 | 5,232 | 22,271 | 17,098 |
| Operating Cash Flow | $-76,143 | $-63,685 | $-52,414 | $-83,297 | $-72,860 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -186,395 | -138,652 | -89,761 | -82,218 | -51,416 |
| PPE Investments | -83 | -83 | -43 | -122 | -121 |
| Purchase Of Investment | 130,619 | 74,410 | 32,740 | 135,042 | 105,082 |
| Investing Cash Flow | $-55,859 | $-64,325 | $-57,064 | $52,702 | $53,545 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 197 | 161 | N/A | 152,852 | 9,737 |
| Financing Cash Flow | $197 | $161 | $N/A | $152,852 | $9,737 |
| Beginning Cash Position | 169,735 | 169,735 | 169,735 | 47,478 | 47,478 |
| End Cash Position | 37,930 | 41,886 | 60,257 | 169,735 | 37,900 |
| Net Cash Flow | $-131,805 | $-127,849 | $-109,478 | $122,257 | $-9,578 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,143 | -63,685 | -52,414 | -83,297 | -72,860 |
| Capital Expenditure | -83 | -83 | -43 | -122 | -121 |
| Free Cash Flow | -76,226 | -63,768 | -52,457 | -83,419 | -72,981 |